Win market research departmental funding, structure teams and insulate market research groups against communication and resource challenges.
Establish competitive intelligence’s importance to your device organization, secure resource support, and align CI with high-level strategic goals.
Deliver maximum strategic impact with a highly visible CI group structured to support strategic planners and C-level decision makers.
Chart the fiercely competitive global oncology market with detailed data for 119 brands — and launch spending benchmarks for key indications.
Track long-term forecasts and in-depth brand profiles of 45 drugs for a comprehensive look at the future of the diabetes market.
Explore analysis and forecasts for 40+ drugs in major autoimmune indications, including rheumatoid arthritis, ulcerative colitis, Crohn’s disease and more.
Harness comprehensive forecasts and strategic profiles for drugs that treat Alzheimer’s, Multiple Sclerosis and Parkinson’s.